Source: Ionis Pharmaceuticals, Inc. | IONS Website
Ticker: IONS
Current Stock Price (02/16/2020): $60.13
Recommendation: Long
Price Target: $71
Company Overview: Ionis Pharmaceuticals, Inc. (IONS), founded in 1989 in the USA, is a specialist in discovering and developing RNA-targeting therapeutics in the US. Their primary specialities are in (1) Rare Drugs, (2) Neurological Drugs, (3) Cardiometabolic & Renal Drugs, and (4) Cancer & Virus Related-Drugs. Typically, Ionis focuses on developing drugs till the completion of Phase 2 where it then sells the rights to a larger pharmaceutical partner for the final stages